Ubiquitin domain proteins in disease

BMC Biochemistry

Volumn 8, Issue SUPPL. 1, 2007, Pages

  Madsen, Louise ^a   Schulze, Andrea ^b   Seeger, Michael ^b   Hartmann Petersen, Rasmus ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 3; CARRIER PROTEIN; ELONGIN B; PARKIN; UBIQUILIN; UBIQUITIN;

ALZHEIMER DISEASE; EUKARYOTIC CELL; HUMAN; NEOPLASM; NERVE DEGENERATION; PARKINSONISM; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; VON HIPPEL LINDAU DISEASE; ANIMAL; CHEMISTRY; DISEASE MODEL; GENE TARGETING; GENETICS; METABOLISM; METHODOLOGY; NEUROLOGIC DISEASE; PROTEIN TERTIARY STRUCTURE;

EUKARYOTA;

ANIMALS; DISEASE MODELS, ANIMAL; GENE TARGETING; HUMANS; NERVOUS SYSTEM DISEASES; PROTEIN STRUCTURE, TERTIARY; UBIQUITIN;

EID: 38449101038     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-8-S1-S1     Document Type: Review

References (74)

1. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. MH Glickman A Ciechanover, Physiol Rev 2002 82 373 428 11917093
2. Mechanisms underlying ubiquitination. CM Pickart, Annu Rev Biochem 2001 70 503 533 10.1146/annurev.biochem.70.1.503 11395416
3. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. M Koegl T Hoppe S Schlenker HD Ulrich TU Mayer S Jentsch, Cell 1999 96 635 644 10.1016/S0092-8674(00)80574-7 10089879
4. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. KD Wilkinson, Semin Cell Dev Biol 2000 11 141 148 10.1006/scdb.2000.0164 10906270
5. A 26 S protease subunit that binds ubiquitin conjugates. Q Deveraux V Ustrell C Pickart M Rechsteiner, J Biol Chem 1994 269 7059 7061 8125911
6. Recognition of the polyubiquitin proteolytic signal. JS Thrower L Hoffman M Rechsteiner CM Pickart, Embo J 2000 19 94 102 10619848 10.1093/emboj/19.1.94
7. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. L Deng C Wang E Spencer L Yang A Braun J You C Slaughter C Pickart ZJ Chen, Cell 2000 103 351 361 10.1016/S0092-8674(00)00126-4 11057907
8. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. KL Lim KC Chew JM Tan C Wang KK Chung Y Zhang Y Tanaka W Smith S Engelender CA Ross VL Dawson TM Dawson, J Neurosci 2005 25 2002 2009 10.1523/JNEUROSCI.4474-04.2005 15728840
9. Protein regulation by monoubiquitin. L Hicke, Nat Rev Mol Cell Biol 2001 2 195 201 10.1038/35056583 11265249
10. Structure of ubiquitin refined at 1.8 Å resolution. S Vijay-Kumar CE Bugg WJ Cook, J Mol Biol 1987 194 531 544 10.1016/0022-2836(87)90679-6 3041007
11. Integral UBL domain proteins: a family of proteasome interacting proteins. R Hartmann-Petersen C Gordon, Semin Cell Dev Biol 2004 15 247 259 10.1016/j.semcdb.2003.12.006 15209385
12. Ubiquitin and its kin: how close are the family ties? S Jentsch G Pyrowolakis, Trends Cell Biol 2000 10 335 342 10.1016/S0962-8924(00)01785-2 10884686
13. Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. CR Wilkinson M Seeger R Hartmann-Petersen M Stone M Wallace C Semple C Gordon, Nat Cell Biol 2001 3 939 943 10.1038/ncb1001-939 11584278
14. Rad23 links DNA repair to the ubiquitin/proteasome pathway. C Schauber L Chen P Tongaonkar I Vega D Lambertson W Potts K Madura, Nature 1998 391 715 718 10.1038/35661 9490418
15. The ubiquitin-domain protein HERP forms a complex with components of the endoplasmic reticulum associated degradation pathway. A Schulze S Standera E Buerger M Kikkert S van Voorden E Wiertz F Koning PM Kloetzel M Seeger, J Mol Biol 2005 354 1021 1027 10.1016/j.jmb.2005.10.020 16289116
16. Transferring substrates to the 26S proteasome. R Hartmann-Petersen M Seeger C Gordon, Trends Biochem Sci 2003 28 26 31 10.1016/S0968-0004(02)00002-6 12517449
17. Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. R Verma R Oania J Graumann RJ Deshaies, Cell 2004 118 99 110 10.1016/j.cell.2004.06.014 15242647
18. Interaction of hHR23 with S5a. The ubiquitin-like domain of hHR23 mediates interaction with S5a subunit of 26 S proteasome. H Hiyama M Yokoi C Masutani K Sugasawa T Maekawa K Tanaka JH Hoeijmakers F Hanaoka, J Biol Chem 1999 274 28019 28025 10.1074/jbc.274.39.28019 10488153
19. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. MF Kleijnen AH Shih P Zhou S Kumar RE Soccio NL Kedersha G Gill PM Howley, Mol Cell 2000 6 409 419 10.1016/S1097-2765(00)00040-X 10983987
20. Proteasome subunit Rpn1 binds ubiquitin-like protein domains. S Elsasser RR Gali M Schwickart CN Larsen DS Leggett B Muller MT Feng F Tubing GA Dittmar D Finley, Nat Cell Biol 2002 4 725 730 10.1038/ncb845 12198498
21. Interaction of the anaphase-promoting complex/cyclosome and proteasome protein complexes with multiubiquitin chain-binding proteins. M Seeger R Hartmann-Petersen CR Wilkinson M Wallace I Samejima MS Taylor C Gordon, J Biol Chem 2003 278 16791 16796 10.1074/jbc.M208281200 12615927
22. Multiple interactions of Rad23 suggest a mechanism for ubiquitylated substrate delivery important in proteolysis. I Kim K Mi H Rao, Mol Biol Cell 2004 15 3357 3365 15121879 10.1091/mbc.E03-11-0835
23. A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. H Richly M Rape S Braun S Rumpf C Hoege S Jentsch, Cell 2005 120 73 84 10.1016/j.cell.2004.11.013 15652483
24. Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. G Wang N Sawai S Kotliarova I Kanazawa N Nukina, Hum Mol Genet 2000 9 1795 1803 10.1093/hmg/9.12.1795 10915768
25. The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. G Nicastro RP Menon L Masino PP Knowles NQ McDonald A Pastore, Proc Natl Acad Sci U S A 2005 102 10493 10498 16020535 10.1073/pnas.0501732102
26. Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. EW Doss-Pepe ES Stenroos WG Johnson K Madura, Mol Cell Biol 2003 23 6469 6483 12944474 10.1128/MCB.23.18.6469-6483. 2003
27. Molecular clearance of ataxin-3 is regulated by a mammalian E4. M Matsumoto M Yada S Hatakeyama H Ishimoto T Tanimura S Tsuji A Kakizuka M Kitagawa KI Nakayama, Embo J 2004 23 659 669 14749733 10.1038/sj.emboj.7600081
28. Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. AL Mah G Perry MA Smith MJ Monteiro, J Cell Biol 2000 151 847 862 10.1083/jcb.151.4.847 11076969
29. Family-based association between Alzheimer's disease and variants in UBQLN1. L Bertram M Hiltunen M Parkinson M Ingelsson C Lange K Ramasamy K Mullin R Menon AJ Sampson MY Hsiao KJ Elliott G Velicelebi T Moscarillo BT Hyman SL Wagner KD Becker D Blacker RE Tanzi, N Engl J Med 2005 352 884 894 10.1056/NEJMoa042765 15745979
30. Alzheimer's disease. K Blennow MJ de Leon H Zetterberg, Lancet 2006 368 387 403 10.1016/S0140-6736(06)69113-7 16876668
31. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. DJ Selkoe, Nat Cell Biol 2004 6 1054 1061 10.1038/ncb1104-1054 15516999
32. GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1. FK Bedford JT Kittler E Muller P Thomas JM Uren D Merlo W Wisden A Triller TG Smart SJ Moss, Nat Neurosci 2001 4 908 916 10.1038/nn0901-908 11528422
33. GABAA receptor channels. RL Macdonald RW Olsen, Annu Rev Neurosci 1994 17 569 602 7516126
34. Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. JT Kittler P Delmas JN Jovanovic DA Brown TG Smart SJ Moss, J Neurosci 2000 20 7972 7977 11050117
35. Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates via a UIM-UBL interaction. E Regan-Klapisz I Sorokina J Voortman P de Keizer RC Roovers P Verheesen S Urbe L Fallon EA Fon A Verkleij A Benmerah PM van Bergen en Henegouwen, J Cell Sci 2005 118 4437 4450 10.1242/jcs.02571 16159959
36. Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins. LK Massey AL Mah DL Ford J Miller J Liang H Doong MJ Monteiro, J Alzheimers Dis 2004 6 79 92 15004330
37. The UBL domain of PLIC-1 regulates aggresome formation. R Heir C Ablasou E Dumontier M Elliott C Fagotto-Kaufmann FK Bedford, EMBO Rep 2006, Published online November 6th 17082820
38. HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. A Iwata BE Riley JA Johnston RR Kopito, J Biol Chem 2005 280 40282 40292 10.1074/jbc.M508786200 16192271
39. Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein. JD Davidson B Riley EN Burright LA Duvick HY Zoghbi HT Orr, Hum Mol Genet 2000 9 2305 2312 11001934
40. The effects of the polyglutamine repeat protein ataxin-1 on the UbL-UBA protein A1Up. BE Riley Y Xu HY Zoghbi HT Orr, J Biol Chem 2004 279 42290 42301 10.1074/jbc.M406284200 15280365
41. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. T Kitada S Asakawa N Hattori H Matsumine Y Yamamura S Minoshima M Yokochi Y Mizuno N Shimizu, Nature 1998 392 605 608 10.1038/33416 9560156
42. Lewy bodies and parkinsonism in families with parkin mutations. M Farrer P Chan R Chen L Tan S Lincoln D Hernandez L Forno K Gwinn-Hardy L Petrucelli J Hussey A Singleton C Tanner J Hardy JW Langston, Ann Neurol 2001 50 293 300 10.1002/ana.1132 11558785
43. Genetics of parkin-linked disease. AB West NT Maidment, Hum Genet 2004 114 327 336 10.1007/s00439-003-1074-6 14727181
44. Parkin is recruited to the centrosome in response to inhibition of proteasomes. J Zhao Y Ren Q Jiang J Feng, J Cell Sci 2003 116 4011 4019 10.1242/jcs.00700 12928331
45. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. H Shimura N Hattori S Kubo Y Mizuno S Asakawa S Minoshima N Shimizu K Iwai T Chiba K Tanaka T Suzuki, Nat Genet 2000 25 302 305 10.1038/77060 10888878
46. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Y Zhang J Gao KK Chung H Huang VL Dawson TM Dawson, Proc Natl Acad Sci U S A 2000 97 13354 13359 11078524 10.1073/pnas.240347797
47. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. Y Imai M Soda R Takahashi, J Biol Chem 2000 275 35661 35664 10.1074/jbc.C000447200 10973942
48. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. KK Chung Y Zhang KL Lim Y Tanaka H Huang J Gao CA Ross VL Dawson TM Dawson, Nat Med 2001 7 1144 1150 10.1038/nm1001-1144 11590439
49. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Y Imai M Soda H Inoue N Hattori Y Mizuno R Takahashi, Cell 2001 105 891 902 10.1016/S0092-8674(01)00407- X 11439185
50. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. H Shimura MG Schlossmacher N Hattori MP Frosch A Trockenbacher R Schneider Y Mizuno KS Kosik DJ Selkoe, Science 2001 293 263 269 10.1126/science.1060627 11431533
51. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. JF Staropoli C McDermott C Martinat B Schulman E Demireva A Abeliovich, Neuron 2003 37 735 749 10.1016/S0896-6273(03)00084-9 12628165
52. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. E Sakata Y Yamaguchi E Kurimoto J Kikuchi S Yokoyama S Yamada H Kawahara H Yokosawa N Hattori Y Mizuno K Tanaka K Kato, EMBO Rep 2003 4 301 306 12634850 10.1038/sj.embor.embor764
53. Parkin-mediated lysine 63-linked polyubiquitination: A link to protein inclusions formation in Parkinson's and other conformational diseases? KL Lim VL Dawson TM Dawson, Neurobiol Aging 2006 27 524 529 10.1016/j.neurobiolaging. 2005.07.023 16213628
54. In vitro assembly and recognition of Lys-63 polyubiquitin chains. RM Hofmann CM Pickart, J Biol Chem 2001 276 27936 27943 10.1074/jbc.M103378200 11369780
55. Structure of S5a bound to monoubiquitin provides a model for polyubiquitin recognition. Q Wang P Young KJ Walters, J Mol Biol 2005 348 727 739 10.1016/j.jmb.2005.03.007 15826667
56. Themes and variations on ubiquitylation. AM Weissman, Nat Rev Mol Cell Biol 2001 2 169 178 10.1038/35056563 11265246
57. rd 16862145
58. Pathogenic mutations inactivate parkin by distinct mechanisms. IH Henn JM Gostner P Lackner J Tatzelt KF Winklhofer, J Neurochem 2005 92 114 122 10.1111/j.1471-4159.2004.02854.x 15606901
59. The cellular protein level of parkin is regulated by its ubiquitin-like domain. N Finney F Walther PY Mantel D Stauffer G Rovelli KK Dev, J Biol Chem 2003 278 16054 16058 10.1074/jbc.C300051200 12621021
60. von Hippel-Lindau disease. RR Lonser GM Glenn M Walther EY Chew SK Libutti WM Linehan EH Oldfield, Lancet 2003 361 2059 2067 10.1016/S0140-6736(03) 13643-4 12814730
61. Molecular basis of the VHL hereditary cancer syndrome. WG Kaelin Jr, Nat Rev Cancer 2002 2 673 682 10.1038/nrc885 12209156
62. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. PH Maxwell MS Wiesener GW Chang SC Clifford EC Vaux ME Cockman CC Wykoff CW Pugh ER Maher PJ Ratcliffe, Nature 1999 399 271 275 10.1038/20459 10353251
63. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. ME Cockman N Masson DR Mole P Jaakkola GW Chang SC Clifford ER Maher CW Pugh PJ Ratcliffe PH Maxwell, J Biol Chem 2000 275 25733 25741 10.1074/jbc.M002740200 10823831
64. Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. T Kamura D Burian Q Yan SL Schmidt WS Lane E Querido PE Branton A Shilatifard RC Conaway JW Conaway, J Biol Chem 2001 276 29748 29753 10.1074/jbc.M103093200 11384984
65. Developmental defects and male sterility in mice lacking the ubiquitin-like DNA repair gene mHR23B. JM Ng H Vrieling K Sugasawa MP Ooms JA Grootegoed JT Vreeburg P Visser RB Beems TG Gorgels F Hanaoka JH Hoeijmakers GT van der Horst, Mol Cell Biol 2002 22 1233 1245 11809813 10.1128/MCB.22.4.1233- 1245.2002
66. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. MS Goldberg SM Fleming JJ Palacino C Cepeda HA Lam A Bhatnagar EG Meloni N Wu LC Ackerson GJ Klapstein M Gajendiran BL Roth MF Chesselet NT Maidment MS Levine J Shen, J Biol Chem 2003 278 43628 43635 10.1074/jbc.M308947200 12930822
67. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. JM Itier P Ibanez MA Mena N Abbas C Cohen-Salmon GA Bohme M Laville J Pratt O Corti L Pradier G Ret C Joubert M Periquet F Araujo J Negroni MJ Casarejos S Canals R Solano A Serrano E Gallego M Sanchez P Denefle J Benavides G Tremp TA Rooney A Brice J Garcia de Yebenes, Hum Mol Genet 2003 12 2277 2291 10.1093/hmg/ddg239 12915482
68. It's a double knock-out! The quaking mouse is a spontaneous deletion of parkin and parkin co-regulated gene (PACRG). PJ Lockhart CA O'Farrell MJ Farrer, Mov Disord 2004 19 101 104 10.1002/mds.20000 14743368
69. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Y Pesah T Pham H Burgess B Middlebrooks P Verstreken Y Zhou M Harding H Bellen G Mardon, Development 2004 131 2183 2194 10.1242/dev.01095 15073152
70. Bortezomib: proteasome inhibition as an effective anticancer therapy. PG Richardson C Mitsiades T Hideshima KC Anderson, Annu Rev Med 2006 57 33 47 10.1146/annurev.med.57.042905.122625 16409135
71. Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain. R Verma NR Peters M D'Onofrio GP Tochtrop KM Sakamoto R Varadan M Zhang P Coffino D Fushman RJ Deshaies RW King, Science 2004 306 117 120 10.1126/science.1100946 15459393
72. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. JS Isaacs YJ Jung EG Mimnaugh A Martinez F Cuttitta LM Neckers, J Biol Chem 2002 277 29936 29944 10.1074/jbc.M204733200 12052835
73. Heat shock protein 90 as a molecular target for cancer therapeutics. JS Isaacs W Xu L Neckers, Cancer Cell 2003 3 213 217 10.1016/S1535-6108(03)00029-1 12676580
74. HSP90 as a new therapeutic target for cancer therapy: the story unfolds. A Maloney P Workman, Expert Opin Biol Ther 2002 2 3 24 10.1517/14712598.2.1.3 11772336